Senolytic treatment effects on adipose tissue cells assessed by single-nuclei RNA sequencing in older obese adults
This randomized controlled trial compared senolytics, lifestyle intervention, and placebo in older obese participants. Researchers performed baseline and post-intervention biopsies of abdominal adipose tissue for single-nuclei RNA sequencing analysis and measured metabolic outcomes including insulin sensitivity, glucose tolerance, and beta-cell function. The abstract provided does not report the study's primary results or findings.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Mar 18, 2026 · Discovered: Sep 16, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- 72
- Duration
- —
- Population
- Older obese participants
- Primary outcome
- Cellular/molecular profiling of adipose tissue and senescent cells via single nuclei RNA-sequencing (snRNA-seq)
- Effect size
- —
- Significance
- Not reported
- Journal
- Cedars-Sinai Medical Center
- Published
- Mar 18, 2026
Sources
Primary source
- Cedars-Sinai Medical Center ↗Clinical trial
Source versions
Assessment history
9/23/2026 · SUPERSEDED: Source updated; assessment withdrawn pending review.
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.